Hydreight Technologies Inc (TSE:NURS) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Hydreight Technologies Inc. reported a record-breaking revenue for the fiscal year 2023, with adjusted revenue soaring by 102% from the previous year and GAAP revenue up by 170%. The company’s expansion efforts have successfully scaled up services to over 700 cities nationwide and grown its medical platform, as evidenced by onboarding 2,249 nurses and being recognized as one of Canada’s Companies to Watch. Amidst this growth, Hydreight has maintained a stable gross margin and continues to enhance its product offerings, including the addition of Semaglutide in December 2023.
For further insights into TSE:NURS stock, check out TipRanks’ Stock Analysis page.
